Jeremy Sokolove

Air Pollution's Hidden Toll: Risks for Rheumatoid Arthritis and Rheumatoid Arthritis-Associated Lung Disease.

Autoantibodies against citrullinated and native proteins and prediction of rheumatoid arthritis-associated interstitial lung disease: a nested case–control study

Lung Inflammation, NETosis, and the Pulmonary Initiation of Anti-Citrullinated Protein Antibody Response: What Came First, the Chicken or the Egg?

Associations of serum cytokines and chemokines with the risk of incident cancer in a prospective rheumatoid arthritis cohort

IgE-mediated mast cell activation promotes inflammation and cartilage destruction in osteoarthritis

A Prospective Study of the Development of Inflammatory Arthritis in the Family Members of Indigenous North American People With Rheumatoid Arthritis

Asthma and elevation of anti-citrullinated protein antibodies prior to the onset of rheumatoid arthritis

THU0689 ASTHMA AND ELEVATION OF ANTI-CITRULLINATED PROTEIN ANTIBODIES PRIOR TO THE ONSET OF RHEUMATOID ARTHRITIS

Enrichment of malondialdehyde–acetaldehyde antibody in the rheumatoid arthritis joint

THU0210 Changes in hemoglobin levels upon treatment with ABT-494, a selective JAK-1 inhibitor, and relation to baseline levels of C-reactive protein

Low-grade inflammation as a key mediator of the pathogenesis of osteoarthritis

<i>Aggregatibacter actinomycetemcomitans</i> –induced hypercitrullination links periodontal infection to autoimmunity in rheumatoid arthritis

CCL2/CCR2, but not CCL5/CCR5, mediates monocyte recruitment, inflammation and cartilage destruction in osteoarthritis

Decreased Synovial Inflammation in Atraumatic Hip Microinstability Compared With Femoroacetabular Impingement

Proceedings of the 2016 Childhood Arthritis and Rheumatology Research Alliance (CARRA) Scientific Meeting

AB0451 NI-0101, a Monoclonal Antibody Targeting Toll Like Receptor 4 (TLR4) Being Developed for Rheumatoid Arthritis (RA) Treatment with a Potential for Personalized Medicine

AB0274 Impact of Baseline Anti-Cyclic Citrullinated Peptide 2 Antibody Titre on Efficacy Outcomes Following Treatment with Subcutaneous Abatacept or Adalimumab: 2-Year Results from the Ample Trial

SAT0074 Effect of Baseline Anti-Cyclic Citrullinated Peptide 2 Antibody Titre on Patient-Reported Outcomes Following Treatment with Subcutaneous Abatacept or Adalimumab

Periodontitis and <i>Porphyromonas gingivalis</i> in Patients With Rheumatoid Arthritis

Rheumatoid Factor as a Potentiator of Anti–Citrullinated Protein Antibody–Mediated Inflammation in Rheumatoid Arthritis

Malondialdehyde‐Acetaldehyde Adducts and Anti–Malondialdehyde‐Acetaldehyde Antibodies in Rheumatoid Arthritis

Alveolar Bone Loss Is Associated With Circulating Anti‐Citrullinated Protein Antibody (ACPA) in Patients With Rheumatoid Arthritis

Role of inflammation in the pathogenesis of osteoarthritis: latest findings and interpretations

Association of fine specificity and repertoire expansion of anticitrullinated peptide antibodies with rheumatoid arthritis associated interstitial lung disease

Identification of anticitrullinated protein antibody reactivities in a subset of anti-CCP-negative rheumatoid arthritis: association with cigarette smoking and HLA-DRB1 ‘shared epitope’ alleles

Relatives Without Rheumatoid Arthritis Show Reactivity to Anti–Citrullinated Protein/Peptide Antibodies That Are Associated With Arthritis‐Related Traits: Studies of the Etiology of Rheumatoid Arthritis

Determinants of Mortality Among Postmenopausal Women in the Women's Health Initiative Who Report Rheumatoid Arthritis

Autoantibody Epitope Spreading in the Pre-Clinical Phase Predicts Progression to Rheumatoid Arthritis

Multiple cytokines and chemokines are associated with rheumatoid arthritis-related autoimmunity in first-degree relatives without rheumatoid arthritis: Studies of the Aetiology of Rheumatoid Arthritis (SERA)